Registration is open for SOSV’s Health Tech VC-Founder Matchup. Learn More

Sensing that changes lives

Team

Sloane Tilley

Co-Founder & CEO

Julio Ortiz

CSO

Fernando Webb

CTO

DIA

Company details

We live in a world where individuals can track their temperature, heart rate, and metabolism in real-time, yet the biochemicals that govern key aspects of our health remain painfully opaque due to a lack of accessible testing. DIA aims to revolutionize the realm of healthcare by making point-of-care, noninvasive sensors that measure many molecules crucial to mental and physical health. We are starting with the immediate measurement of basic metabolic biomarkers in saliva using a small table-top device. The data can be immediately transferred to a healthcare professional or caretaker for better monitoring and treatment of the 40+ million Americans living with heart and kidney failure.

Get In Touch with DIA

Please tell us a little bit about yourself and why you'd like to get connected. DIA + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More